We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXC icon
251
DXC Technology
DXC
$1.73B
$9.31M 0.06%
168,733
+120,739
+252% +$6.99M
FE icon
252
FirstEnergy
FE
$27.5B
$9.24M 0.06%
215,734
-89,751
-29% -$3.77M
BR icon
253
Broadridge
BR
$19B
$9.23M 0.06%
72,314
+14,894
+26% +$1.79M
APD icon
254
Air Products & Chemicals
APD
$67.6B
$9.19M 0.06%
40,586
-24,856
-38% -$5.15M
LINX
255
DELISTED
Linx S.A.
LINX
$9.12M 0.06%
+1,000,000
New +$9.03M
NOMD icon
256
Nomad Foods
NOMD
$1.68B
$9.12M 0.06%
426,949
-135,282
-24% -$2.84M
CELG
257
DELISTED
Celgene Corp
CELG
$9.08M 0.06%
98,198
+16,262
+20% +$1.54M
PAGP icon
258
Plains GP Holdings
PAGP
$4.9B
$9.07M 0.06%
363,323
+354,183
+3,875% +$8.56M
WBS icon
259
Webster Financial
WBS
$12.8B
$9.05M 0.06%
+189,559
New +$9.44M
ULTA icon
260
Ulta Beauty
ULTA
$24.3B
$8.88M 0.06%
25,608
-375
-1% -$130K
ELF icon
261
e.l.f. Beauty
ELF
$5.8B
$8.86M 0.06%
628,389
+590,936
+1,578% +$7.15M
WRI
262
DELISTED
Weingarten Realty Investors
WRI
$8.83M 0.05%
322,149
+319,649
+12,786% +$9.2M
SNAP icon
263
Snap
SNAP
$9.01B
$8.39M 0.05%
586,564
-144,682
-20% -$1.77M
HMSY
264
DELISTED
HMS Holdings Corp.
HMSY
$8.21M 0.05%
253,304
+135,321
+115% +$4.14M
GIB icon
265
CGI
GIB
$15.5B
$8.19M 0.05%
106,345
+60,845
+134% +$4.42M
EBIX
266
DELISTED
Ebix Inc
EBIX
$8.16M 0.05%
162,472
+29,713
+22% +$1.48M
EQNR icon
267
Equinor
EQNR
$92.4B
$8.1M 0.05%
409,657
+388,201
+1,809% +$8.19M
SIVB
268
DELISTED
SVB Financial Group
SIVB
$8.02M 0.05%
+35,704
New +$8.26M
CBRE icon
269
CBRE Group
CBRE
$42.9B
$8.01M 0.05%
156,122
-382,802
-71% -$19M
HCC icon
270
Warrior Met Coal
HCC
$4.86B
$7.94M 0.05%
304,035
+129,427
+74% +$3.69M
TMX
271
DELISTED
Terminix Global Holdings, Inc.
TMX
$7.9M 0.05%
151,569
+145,979
+2,611% +$7.51M
RNG icon
272
RingCentral
RNG
$5.28B
$7.79M 0.05%
67,827
+64,814
+2,151% +$7.47M
TSCO icon
273
Tractor Supply
TSCO
$18.1B
$7.78M 0.05%
357,485
-318,870
-47% -$6.59M
TNDM icon
274
Tandem Diabetes Care
TNDM
$1.53B
$7.74M 0.05%
120,012
-10,825
-8% -$699K
EWBC icon
275
East-West Bancorp
EWBC
$18B
$7.72M 0.05%
165,115
+65,899
+66% +$3.16M
9 10
11
12 13

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.